Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in VCYT — Veracyte, Inc.

CIK 80255 BALTIMORE, MD
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,437,101
+$3,507,666 QoQ
Shares Held
109,605
+20.5% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 367 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $14,000,860,485 across 31 Diagnostics & Research names. VCYT ranks #20 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 5,116,336 $2,565,126,216
2 NTRA
Natera, Inc.
 9,021,895 $2,448,993,397
3 DHR
Danaher Corp /De/
 11,450,715 $2,181,132,192
4 DGX
Quest Diagnostics Inc
 5,444,986 $1,154,064,781
5 MEDP
Medpace Holdings, Inc.
 2,069,677 $1,096,080,242
6 GH
Guardant Health, Inc.
 6,514,952 $977,438,248
7 WAT
Waters Corp /De/
 2,177,958 $816,821,367
8 RVTY
Revvity, Inc.
 5,530,850 $615,362,370

All Filings in VCYT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,437,101 109,605
2026-03-31 $2,929,435 90,948
2025-12-31 $3,143,943 74,678
2025-09-30 $2,361,801 68,797
2025-06-30 $1,749,760 64,734
2025-03-31 $1,713,858 57,803
2024-12-31 $1,917,194 48,414
2024-09-30 $1,586,195 46,598
2024-06-30 $968,735 44,704
2024-03-31 $909,468 41,041
2023-12-31 $1,011,955 36,785
2023-09-30 $676,286 30,286
2023-06-30 $859,587 33,749
2023-03-31 $705,795 31,650
2022-12-31 $721,581 30,408
2022-09-30 $520,144 31,334
2022-06-30 $617,616 31,036
2022-03-31 $785,717 28,499
2021-12-31 $968,241 23,501
2021-09-30 $1,480,129 31,865
2021-06-30 $1,223,547 30,604
2021-03-31 $1,502,366 27,951
2020-12-31 $737,232 15,064
2020-09-30 $815,726 25,107
2020-06-30 $269,593 10,409
2020-03-31 $535,768 22,039